Endeavor

New Data May Change Approach to Treating Multiple Myeloma, Ewing Sarcoma and Breast Cancer

ASCO studies show benefit to reevaluating current standard of care for these diseases

Studies Highlight Optimizing Therapy in Colon and Breast Cancer

Better targeting treatment approaches can greatly reduce toxicities

Can the Gut Microbiome Predict Response to Cancer Treatment?

New study suggests so for recurrent metastatic head and neck cancer patients

Guiding the Future of Targeted Therapies for Pancreatic Cancer

Molecular sequencing gives researchers a look at the genetic landscape of tumors

Moffitt Researchers Use Explainable AI to Investigate and Predict the Survival Efficacy of Immunotherapy Drug

Data presented at ASCO help researchers get a deeper understanding of immune checkpoint inhibitors efficiency in patients

Adding Ibrutinib to Standard of Care Improves Progression Free Survival in Older Patients with Mantle Cell Lymphoma

However, experts say it may be too soon to say new phase 3 trial data is practice changing

Genomics, Not Specific Tumor Sites, Could Influence Future Cancer Treatment

New research suggests LAG3 could be the next big target for personalized therapy

Moffitt’s Magnolia Ball Raises $3.2 Million to Advance Standard of Care for Cancer

The 27th annual gala returns after two years

Moffitt Connects with Employer Partners for a Day of Cancer Screening

Over 100 people screened during the cancer center’s first Moffitt Connect Day